Jaguar Health, Inc. (JAGX): debt financing — Jaguar Health extends note maturity to July 2025, issues shares to reduce royalty liability

Jaguar Health, Inc.

Note amendment with Streeterville Capital extends maturity of $6.22M secured promissory note to July 20, 2025.
Issued 1,290,000 common shares in exchange for $1,094,952 reduction in outstanding royalty interest balance.
Share issuance conducted under Section 3(a)(9) exemption from registration.
Exchange agreement with royalty holder is a privately negotiated transaction reducing debt-like obligation.

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Jaguar Health, Inc. amended senior notes of $6,220,812.50 with Streeterville Capital, LLC maturing July 20, 2025.

Instrument: senior notes
Principal: $6,220,812.50
Counterparty: Streeterville Capital, LLC
Maturity: July 20, 2025
Event: amendment

Exact text from the filing

entered into an amendment (the “Note Amendment”) with Streeterville Capital, LLC (“Streeterville”) to the secured promissory note in the original principal amount of $6,220,812.50 (as amended, the “Note”) issued by Borrower to Streeterville on January 19, 2021 pursuant to that certain Note Purchase Agreement among the same parties dated as of the even date

View on SEC.gov

24 debt financings filed in the last 30 days. Browse all debt financings →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-019416

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.